GlassScriptPhysician profile
Amanda Lynn Grecu
NPI 1164896338
$2,057.53
in general payments reported to CMS, 2019-2025
21 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $629 · 2022: $576 · 2023: $242 · 2024: $403 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $599.57 | 2021-2025 | |
| Lilly USA, LLC | $290.66 | 2021-2023 | Taltz |
| Ucb, INC. | $227.57 | 2021-2023 | Cimzia |
| Genzyme Corporation | $157.02 | 2021-2025 | |
| Janssen Biotech, INC. | $135.69 | 2022-2025 | Tremfya, Simponi Aria, Stelara |
| Amgen INC. | $110.15 | 2022-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $70.77 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $66.13 | 2023 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $64.36 | 2022-2025 | |
| Leo Pharma INC. | $59.68 | 2022 | |
| Arcutis Biotherapeutics, INC. | $50.83 | 2023-2024 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.09 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.69 | 2021-2022 | |
| Pfizer INC. | $27.81 | 2021-2022 | |
| Incyte Corporation | $22.16 | 2024 | Opzelura |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $20.28 | 2021 | |
| Organogenesis INC. | $19.37 | 2022 | |
| Organon LLC | $18.43 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $18.14 | 2021 | |
| Next Science LLC | $17.70 | 2024 | Blastx, Xperience, Surgx |
| Dermavant Sciences, INC. | $16.43 | 2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Grecu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.